---
id: campylobacter-jejuni_056
category: organisms
tags: [campylobacter-jejuni, gastroenteritis, guillain-barre-syndrome, azithromycin, bloody-diarrhea]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## Campylobacter jejuni: Gastroenteritis & Guillain-Barré Syndrome

**Q:** What are the clinical features, complications (especially Guillain-Barré syndrome), and treatment of Campylobacter jejuni infection?

**A:**

**Microbiology:**
- **Gram-negative, curved/spiral rod** ("comma-shaped" or "seagull" morphology)
- Microaerophilic (requires reduced oxygen)
- Thermophilic (grows at 42°C)
- Motile (polar flagella - "darting" corkscrew motility)

**Epidemiology:**
- **Most common bacterial cause of gastroenteritis** in developed countries
- Zoonotic: Poultry (most common), cattle, dogs, cats
- Transmission: Contaminated food (undercooked chicken), unpasteurized milk, contaminated water

---

**Clinical Presentation:**

**Incubation:** 2-5 days (range 1-10 days)

**Acute Gastroenteritis:**

**Prodrome (1-2 days):**
- Fever, headache, myalgias

**Gastrointestinal Phase:**
- **Diarrhea:** Watery → bloody (in 15-50%)
- **Severe abdominal cramps** (may mimic appendicitis)
- **Fever** (common)
- Nausea, vomiting (less common)
- **Fecal leukocytes** present (inflammatory diarrhea)

**Duration:** 3-7 days (self-limited)

**Key Feature:**
- **Colitis-like picture:** Severe cramps + bloody diarrhea mimics inflammatory bowel disease or ischemic colitis

---

**Complications:**

**1. Guillain-Barré Syndrome (GBS):**

**Epidemiology:**
- **C. jejuni is #1 infection preceding GBS** (20-50% of GBS cases)
- GBS develops 1-3 weeks after gastroenteritis (median 10 days)

**Pathophysiology:**
- **Molecular mimicry:** C. jejuni lipooligosaccharides (LOS) resemble human gangliosides (GM1, GD1a)
- Cross-reactive antibodies attack peripheral nerve myelin
- Axonal degeneration in severe cases

**Clinical Features:**
- Ascending symmetric weakness (legs → arms)
- Areflexia
- Respiratory failure (30% require ventilation)

**Prognosis:**
- **GBS from C. jejuni = more severe** (more axonal degeneration, slower recovery)
- 5-10% mortality

**Important:**
- **Antibiotics for gastroenteritis do NOT prevent GBS** (molecular mimicry triggered by infection, not ongoing bacterial presence)

**2. Reactive Arthritis (1-5%):**
- Oligoarthritis 1-3 weeks post-infection
- Knees, ankles most common
- Often HLA-B27 positive

**3. Bacteremia (Rare):**
- Immunocompromised, elderly, extremes of age
- May require antibiotics

**4. Other:**
- Hemolytic uremic syndrome (HUS) - rare
- Toxic megacolon - rare

---

**Diagnosis:**

**Stool Culture (Gold Standard):**
- Requires special media: **Campy-selective agar** (Skirrow, Butzler)
- Incubation at 42°C, microaerophilic atmosphere
- Culture sensitivity: 80-90%

**PCR (Multiplex GI Panels):**
- More sensitive than culture
- Rapid (24h)
- Increasingly preferred

**Microscopy:**
- Curved/spiral rods on Gram stain
- "Darting" motility on dark-field or phase-contrast

**Not Useful:**
- Serology (retrospective only)

---

**Treatment:**

**1. Supportive Care (Most Cases):**

**Indications for NO Antibiotics:**
- Mild gastroenteritis
- Symptoms <3 days
- Immunocompetent

**Supportive Only:**
- Oral rehydration
- Anti-motility agents (avoid if bloody diarrhea or fever)

**Self-Limited:** Resolves in 3-7 days

**2. Antibiotics (Selective Use):**

**Indications:**
- **Severe or prolonged diarrhea** (>7 days)
- **Bloody diarrhea with systemic symptoms**
- **Immunocompromised** (HIV, transplant)
- **Pregnancy**
- **Bacteremia**

**Antibiotic Options:**

| **Antibiotic** | **Dosing** | **Duration** | **Notes** |
|----------------|------------|--------------|-----------|
| **Azithromycin** (preferred) | 500 mg PO daily | 3 days | Preferred due to ↑ FQ resistance |
| **Fluoroquinolones** | Ciprofloxacin 500 mg PO BID | 3-5 days | ↑ Resistance in US, avoid if possible |
| **Erythromycin** | 500 mg PO QID | 5 days | Alternative (GI side effects) |

**Resistance:**
- **Increasing fluoroquinolone resistance** (>20% in US, >90% in Southeast Asia)
- **Azithromycin preferred** (low resistance)

**Key Point:**
- Antibiotics shorten illness **IF started early** (<3 days of symptoms)
- No benefit if started after 4-5 days
- **Do NOT prevent GBS**

**3. Guillain-Barré Syndrome Management:**
- **IVIG** (0.4 g/kg/day x 5 days) OR
- **Plasma exchange** (5 sessions over 2 weeks)
- Supportive care (respiratory monitoring, DVT prophylaxis)

---

**Mnemonic: "CAMPY = Causes Acute Myalgias, Prodrome, then Yields GBS"**
- **C**urved rod (comma/seagull shape)
- **A**cute gastroenteritis (#1 bacterial cause)
- **M**yalgias + fever (prodrome)
- **P**oultry (undercooked chicken)
- **Y**ields GBS (1-3 weeks later)

**Mnemonic: "GBS Chicken Link"**
- **G**uillain-Barré syndrome
- **B**loody diarrhea + cramps
- **S**eafood... NO! **Chicken** (undercooked poultry)

**Clinical Pearls:**
- **C. jejuni = #1 bacterial cause of gastroenteritis** in developed world
- **C. jejuni = #1 infection preceding GBS** (20-50% of GBS cases)
- Think C. jejuni: Bloody diarrhea + severe cramps + undercooked chicken
- **GBS from C. jejuni is MORE severe** (axonal type, slower recovery)
- Antibiotics shorten illness but **do NOT prevent GBS**
- Azithromycin preferred over fluoroquinolones (rising resistance)
- Most cases self-limited → supportive care only
- **If patient develops ascending weakness 1-3 weeks after diarrhea → think GBS**

**Media:** None

**Sources:** [CDC 2024 - Clinical overview Campylobacter], [Merck Manual 2024 - Campylobacter infections], [Johns Hopkins Medicine 2024], [PMC 2022 - C. jejuni predominates in GBS], [NEJM 1995 - C. jejuni and GBS], [Medscape 2024 - Campylobacter treatment], [PMC 2023 - Erythromycin resistance in Shanghai]
